Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$132,051,955
+$7,699,461 QoQ
Shares Held
519,951
+2.2% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
1.04%
of 13F equity value
Holder Rank
#261
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Erste Asset Management GmbH holds $588,715,782 across 9 Drug Manufacturers - General names. JNJ ranks #2 (22.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
130,143 | $156,097,431 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
519,951 | $132,051,955 | |
| 3 | MRK |
Merck & Co., Inc.
|
571,075 | $73,383,137 | |
| 4 | ABBV |
AbbVie Inc.
|
267,697 | $67,363,272 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
426,561 | $53,891,716 | |
| 6 | AMGN |
Amgen Inc
|
128,052 | $46,370,190 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
420,361 | $24,221,200 | |
| 8 | PFE |
Pfizer Inc
|
869,213 | $20,930,649 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $132,051,955 | 519,951 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $124,352,494 | 508,724 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $76,240,173 | 368,399 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $61,872,428 | 333,688 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $53,164,790 | 348,051 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $38,658,464 | 233,107 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $17,542,641 | 181,021 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $30,874,050 | 190,510 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $26,301,784 | 179,952 | Shares | Sole | 2024-11-26 | |
| 2024-03-31 | $26,605,659 | 168,188 | Shares | Sole | 2024-11-26 | |
| 2023-12-31 | $29,468,373 | 188,008 | Shares | Sole | 2024-11-26 | |
| 2023-09-30 | $34,744,398 | 223,078 | Shares | Sole | 2024-11-26 | |
| 2023-06-30 | $36,204,024 | 218,729 | Shares | Sole | 2024-11-26 | |
| 2023-03-31 | $28,081,660 | 181,172 | Shares | Sole | 2024-11-26 | |
| 2022-12-31 | $30,612,031 | 173,292 | Shares | Sole | 2024-11-26 | |
| 2022-09-30 | $35,542,561 | 217,572 | Shares | Sole | 2024-11-26 | |
| 2022-06-30 | $34,767,463 | 195,862 | Shares | Sole | 2024-11-26 | |
| 2022-03-31 | $27,930,030 | 157,592 | Shares | Sole | 2024-11-25 | |
| 2021-12-31 | $26,500,624 | 154,911 | Shares | Sole | 2024-11-25 | |
| 2021-09-30 | $18,955,739 | 117,373 | Shares | Sole | 2024-11-25 | |
| 2021-06-30 | $7,708,019 | 46,789 | Shares | Sole | 2024-11-25 | |
| 2021-03-31 | $7,051,436 | 42,905 | Shares | Sole | 2024-11-25 | |
| 2020-12-31 | $4,668,992 | 29,667 | Shares | Sole | 2024-11-25 | |
| 2020-09-30 | $3,620,761 | 24,320 | Shares | Sole | 2024-11-25 | |
| 2020-06-30 | $3,324,915 | 23,643 | Shares | Sole | 2024-11-22 | |
| 2020-03-31 | $2,973,372 | 22,675 | Shares | Sole | 2024-11-22 | |
| No filing history on record for this holder in this stock. | ||||||